Advertisement

Classification of Myelin Disorders

  • Marjo S. van der Knaap
  • Jacob Valk

Abstract

The history of classifications of myelin disorders shows how each classification reflects the state of scientific development of its time. Based on recent scientific insights, a revised classification is proposed at the end of this chapter.

Keywords

Neuronal Ceroid Lipofuscinosis Maple Syrup Urine Disease Metachromatic Leukodystrophy Central Pontine Myelinolysis Demyelinating Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams RD, Kubik CS (1952) The morbid anatomy of the demyelinative diseases. Am J Med 12: 510–546PubMedCrossRefGoogle Scholar
  2. Adams RD, Richardson EP (1961) The demyelinative diseases of the human nervous system. In: Folch PI (eds) Chemical pathology of the nervous system. Pergamon, Oxford, pp 162–194Google Scholar
  3. Allan VI (1984) Demyelinating diseases. In: Adams HJ, Corsellis JAN, Duchen LW (eds) Greenfields neuropathology. Arnold, London, pp 338–384Google Scholar
  4. Alzheimer A (1910) Beiträge zur Kenntnis der pathologischen Neuroglia und ihrer Beziehungen zu den Abbauvorgängen im Nervengewebe. Nissl Alzheimer Arbeiten 3: 401–562Google Scholar
  5. Austin J, McAfee D, Armstrong D, ORourke M, Shearer L, Bachhawat B (1964) Low sulfatase activities in metachromatic leukodystrophy. Trans Am Neurol Assoc J 89: 147150Google Scholar
  6. Bérard-Badier M, Paillas JE, Gastaut H, Edgar GWF (1958) Essai sur la significance des démyelinisations dans lidiotie amaurotique infantile. Psychiatr Neurol 132: 50–93CrossRefGoogle Scholar
  7. Bielschowsky M, Henneberg R (1928) Über familiäre diffuse Sklerose (leukodystrophia cerebri progressiva hereditaria). J Psychol Neurol 36: 131–181Google Scholar
  8. Blackwood W (1957) The histological classification of diffuse demyelinating cerebral sclerosis. In: Cerebral lipidosis, a symposium. Blackwell Scientific, Oxford, pp 1–10Google Scholar
  9. Carswell R (1838) Pathological anatomy:illustrations of the elementary forms of disease. Longmans Green, LondonGoogle Scholar
  10. Challa VR (1987) White matter lesions in MR imaging of elderly subjects. Radiology 164: 874–875PubMedGoogle Scholar
  11. Charcot JM (1868) Lectures on the diseases of the nervous system, vol 3. New Sydenham Society, London (Lectures delivered in 1868, English translation published in 1877 )Google Scholar
  12. Cruveilhier J (1835–1842) Anatomie pathologique du corps humain, vol II, fascicle XXXII. Bailliere, ParisGoogle Scholar
  13. Davison AN, Dobbing J (1966) Myelination as vulnerable period in brain development. Br Med Bull 20: 40–44Google Scholar
  14. Diezel PB (1955) Histochemische Untersuchungen an den Globoidzellen der familiaeren infantilen diffusen Sklerose vom Typus Krabbe. Virchows Arch Pathol Anat 327: 206–228CrossRefGoogle Scholar
  15. Edgar GWF (1955) Approche biochimique des lipidoses et des leucodystrophies. Rev Neurol 92: 277–284PubMedGoogle Scholar
  16. Fardeau M, Lapresle J (1963) Maladie de Tay-Sachs avec atteinte importante de la substance blanche. A propos de deux observations anatomo-cliniques. Rev Neurol 109: 157175Google Scholar
  17. Fölling A (1934) Ueber Ausscheiding von Phenylbrenztraubensäure in den Ham als Stoffwechselanomalie in Verbindung mit Imbezillität. Z Physiol Chem 227: 169–176CrossRefGoogle Scholar
  18. George AE, de Leon MJ, Gentes CI, Miller J, London E, Budzilovich GN, Ferris S, Chase N (1986) Leukoencephalpathy in normal and pathologic aging:CT of brain lucencies. AJNR 7: 561–566PubMedGoogle Scholar
  19. Gupta SR, Naheedy MH, Young JC, Ghobrial M, Rubino FA, Hindo W (1988) Periventricular white matter changes and dementia. Clinical, neuropsychological, radiological and pathological correlation. Arch Neurol 45: 637–641Google Scholar
  20. Hallervorden J (1940) Die zentralen Entmarkungskrankheiten. Dtsch Z Nervenheilkd 150: 201–239CrossRefGoogle Scholar
  21. Hauw JJ, Delaère P, Seilhean D, Cornu P (1992) Morphology of demyelination in the human central nervous system. J Neuroimmunol 40: 139–152PubMedCrossRefGoogle Scholar
  22. Herschkowitz N, Schulte FJ (1984) The lipidoses:from detect to dysfunction. Neuropediatrics 15: 110–111CrossRefGoogle Scholar
  23. Heubner O (1897) Über diffuse Hirnsklerose. Charite Ann 22: 298–310Google Scholar
  24. Huk WJ, Bydder GM, Curati WL (1990) Degenerative disorders of the brain and white matter diseases. In: Huk WJ, Gademann G, Friedmann G (eds) Magnetic resonance imaging of central nervous system diseases. Springer, Berlin Heidelberg New York, pp 197–224CrossRefGoogle Scholar
  25. Jervis GA (1947) Studies on phenylpyruvic oligofrenia:the po- sition of the metabolic error. J Biol Chem 169: 651–656PubMedGoogle Scholar
  26. Johnson MA, Pennock JM, Bydder GM, Steiner RE, Thomas DJ, Hayward R, Bryant DRT, Payne JA, Levene MI, Whitelaw A, Dubowitz LMS, Dubowitz V (1983) Clinical NMR imaging of the brain in children: normal and neurologic disease. AJR 141: 1005–1018PubMedCrossRefGoogle Scholar
  27. Krabbe K (1916) A new familial infantile form of diffuse brain-sclerosis. Brain 39: 74–114CrossRefGoogle Scholar
  28. Lassmann H, Ammerer HP, Kulnig W (1978) Ultrastructural sequence of myelin degradation. Wallerian degeneration in the rat optic nerve. Acta Neuropathol (Berl) 44: 91–102Google Scholar
  29. Matthieu JM (1993) An introduction to the molecular basis of inherited myelin diseases. J Inherited Metab Dis 16: 724732Google Scholar
  30. Menkes JH (1990) The leukodystrophies. N Engl J Med 322: 54–55PubMedCrossRefGoogle Scholar
  31. Merzbacher L (1910) Eine eigenartige familiär-hereditäre Erkrankungsform (aplasia axialis extracorticalis congenita). Z Gesamte Neurol Psychiatr 3: 1–138CrossRefGoogle Scholar
  32. Morell P, Wiesmann U (1984) A correlative synopsis of the leukodystrophies. Neuropediatrics 15 Supp1: 62–65Google Scholar
  33. Neubürger K (1921) Histologisches zur Frage der diffusen Hirnsklerose. Z Gesamte Neurol Psychiatr 73: 336–352CrossRefGoogle Scholar
  34. Peiffer J (1962) Differentiation of various types of leukodystrophy. World Neurol 3: 580–597Google Scholar
  35. Pelizaeus F (1899) Über eine eigenartige familiäre Entwicklungshemmung vornehmlich auf motorischem Gebiet. Arch Psychiatr Nervenkr 31: 100–104Google Scholar
  36. Poser CM (1957) Discussion des rapports sur les maladies demyelinisantes. Proceedings of the 3rd international congress on neuropathology, Brussels. Editions Acta Medica Belgica, pp 106–111Google Scholar
  37. Poser CM (1961) Leukodystrophy and the concept of dysmyelination. Arch Neurol 4: 323–332PubMedCrossRefGoogle Scholar
  38. Poser CM (1978) Dysmyelination revisited. Arch Neurol 35: 401–407PubMedCrossRefGoogle Scholar
  39. Poser CM (1987) The dysmyelinating diseases. In: Baker AB, Joynt RJ (eds) Clinical neurology, vol 3. Harper and Row, Philadelphia, chap 34Google Scholar
  40. Raine CS (1984) The neuropathology of myelin diseases. In: Morel! P (ed) Myelin, 2nd edn. Plenum, New York, pp 259310Google Scholar
  41. Ranvier L (1871) Contribution à lhistologie et à la physiologie des nerfs periphériques. CR Acad Sci 73: 1168Google Scholar
  42. Ranvier L (1875) Traité technique dhistologie. Savy, Paris Schilder P (1912) Zur Kenntnis der sogenannten diffusen Sklerose. Über Encephalitis periaxialis diffusa. Z Gesamte Neurol Psychiatr 10: 1–60CrossRefGoogle Scholar
  43. Scholz W (1925) Klinische, pathologisch-anatomische und erbbiologische Untersuchungen bei familiärer, diffuser Hirnsklerose im Kindesalter. Z Gesamte Neurol Psychiatr 99: 651–717CrossRefGoogle Scholar
  44. Seitelberger F (1984) Structural manifestations of leukodystrophies. Neuropediatrics 15 Suppl: 53–61Google Scholar
  45. Stam FC, Heslinga JM, Deierkauf FA, Booij HL (1962) Leukodystrophy of the Norman-Greenfield and Krabbe type. Psychiatr Neurol Neurosurg 65: 254–265Google Scholar
  46. Stam FC (1970) Concept, classification and nosology of the leukodystrophies. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 10. North Holland, Amsterdam, pp 1–42Google Scholar
  47. Suzuki K, Suzuki Y (1970) Globoid cell leukodystrophy (Krabbes disease): deficiency of galactocerebroside betagalactosidase. Proc Natl Acad Sci USA 66: 302–309PubMedCrossRefGoogle Scholar
  48. Thieffry S, Bertrand I, Bargeton E, Edgar GWF, Arthuis M(1960) Idiotie amaurotique infantile ave alterations graves de la substance blanche. Rev Neurol 102: 130–152Google Scholar
  49. Virchow R (1854) Ueber das ausgebreitete Vorkommen einer dem Nervenmark analogen Substanz in den thierischen Geweben. Virchows Arch Pathol Anat: 562–572Google Scholar
  50. Von Hirsch T, Peiffer J (1955) Über histologische Methoden in der Differentialdiagnose von Leukodystrophien und Lipidosen. Arch Psychiatr Z Neurol 194: 88–104CrossRefGoogle Scholar
  51. Von Hirsch T, Peiffer J (1957) A histochemical study of the pre-lipid and metachromatic degenerative products in leucodystrophy. In: Cerebral lipidoses, a symposium. Blackwell Scientific, Oxford, pp 68–76Google Scholar
  52. Von Hirsch T, Peiffer J (1957) A histochemical study of the pre-lipid and metachromatic degenerative products in leucodystrophy. In: Cerebral lipidoses, a symposium. Blackwell Scientific, Oxford, pp 68–76Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Marjo S. van der Knaap
    • 1
  • Jacob Valk
    • 2
  1. 1.Department of Child NeurologyFree University HospitalAmsterdamThe Netherlands
  2. 2.Department of Diagnostic RadiologyFree University HospitalAmsterdamThe Netherlands

Personalised recommendations